Mark J. Ratain to Carboplatin
This is a "connection" page, showing publications Mark J. Ratain has written about Carboplatin.
Connection Strength
0.589
-
Current dilemmas in carboplatin dosing. Clin Adv Hematol Oncol. 2011 Mar; 9(3):237-8.
Score: 0.365
-
Phase I study of escalating does of carboplatin. Cancer Chemother Pharmacol. 1994; 34(6):535-6.
Score: 0.111
-
Genome-wide association studies of survival in 1520 cancer patients treated with bevacizumab-containing regimens. Int J Cancer. 2022 01 15; 150(2):279-289.
Score: 0.048
-
Body surface area as a determinant of pharmacokinetics and drug dosing. Invest New Drugs. 2001 May; 19(2):171-7.
Score: 0.046
-
The Werner's syndrome 4330T>C (Cys1367Arg) gene variant does not affect the in vitro cytotoxicity of topoisomerase inhibitors and platinum compounds. Cancer Chemother Pharmacol. 2009 Apr; 63(5):881-7.
Score: 0.019